Intelligence Platform

Patents

Browse 163 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9434931

Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

Precision BioSciences, Inc. · Granted Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9370559

Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number

The United States of America, as represented by the Secretary, Department of Heath Services · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9340777

Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

Precision BioSciences, Inc. · Granted Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9260726

Targeted integration and expression on exogenous nucleic acid sequences

Sangamo Biosciences, Inc. · Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9212218

Vmp-like sequences of pathogenic Borrelia

The Board of Regents of the University of Texas System · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9200281

Conserved HBV and HCV sequences useful for gene silencing

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9187523

Substrate peptide sequences for plague plasminogen activator and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9155801

Amino acid sequences which enhance peptide conjugate solubility

United States Government as represented by the Department of Veterans Affairs · Granted Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9133478

Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9115193

VMP-like sequences of pathogenic Borrelia species and strains

The Board of Regents of the University of Texas System · Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9109014

Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vacc

Inovio Pharmaceuticals, Inc. · Granted Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8999705

Bifidobacterial gene sequences and their use

The Regents of the University of California · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8957192

Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8871447

Immunogens and corresponding antibodies specific for high molecular weight aggregation int

The Regents of the University of California · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8841120

Virus-like particles comprising composite capsid amino acid sequences for enhanced cross r

Takeda Vaccines, Inc. · Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8722871

VMP-like sequences of pathogenic borrelia species and strains

The Board of Regents of the University of Texas System · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8709774

Sperm factor sequences

University College Cardiff Consultants Limited · Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8703150

Methods of using Bacillus anthracis protective antigen sequences for vaccination

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8691241

Reoviruses having modified sequences

ONCOLYTICS BIOTECH INC. · Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8575327

Conserved HBV and HCV sequences useful for gene silencing

Alnylam Pharmaceuticals, Inc. · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8563503

Antibiotic, its nucleotide sequence, methods of construction and uses thereof

PROTEIN DESIGN LAB, LTD. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8513005

DNA immunogenic composition comprising a full-length modified poxvirus L1R gene fused to a

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8506947

Vaccinia virus expression vector for selective replication in a tumor cell and introductio

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8501920

Nucleic acid sequences encoding peptides with utrophin spectrin-like repeats

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted